This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2.
There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.
Now, a research group at the Medical College of Georgia at Augusta University has been awarded a $1.8 Now, a research group at the Medical College of Georgia at Augusta University has been awarded a $1.8 Inhibition of MAGL using cannabinoids. The research at the focus of the new $1.8 Why, how, and when intervene?
Australian biotechnology company CannaPacific and the University of Newcastle have announced a collaboration to advance the development of new cannabinoid-based pain treatments. … Read More.
In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Around 10-20% of patients stopped taking various medications (mostly antipsychotic and antiepileptic drugs) within 6 months of starting cannabis treatment.
A 2006 edition of Current Pharmacology published an article titled: “Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes”. Cannabinoid Receptors , referred to as CB1 and CB2, are an essential part of the human body’s endocannabinoid system.
Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . Research Team to Study the Impact of CBD on Spinal Injury Pain. Dr. Carins is a postdoctoral researcher who completed her Ph.D. Lambert Initiative experts have won $1.7
The 29th annual International CannabinoidResearch Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. 1 So can cannabis cure cancer?
Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.
Cannabis has long been used to aid with the treatment of cancer due to its ability to reduce nausea, reduce inflammation, stimulate appetite and reduce pain while promoting homeostasis in the body. CBG, or Cannabigerol , is a cannabinoid compound from the cannabis plant. What is CBG? What is Glioblastoma? .
One of the biggest areas of contention in the public debate about cannabis legalization is the viability of medicinal cannabis as a treatment for many mental health disorders, such as anxiety, depression, bipolar disorder, schizophrenia, and others. What Does Available Cannabis Research Tell Us? CBD for Mental Health Treatment.
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.
The 29th annual International CannabinoidResearch Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
A team of researchers at Australia’s University of Queensland and at Botanix Pharmaceuticals Limited found, for the first time, that CBD is effective in killing Gram-negative bacteria which could mean that a new class of antibiotics can be developed for bacteria which is resistant to other forms of pharmaceutical medications. .
In Florida, glaucoma is listed as a condition eligible for medical marijuana treatment. Cannabinoids and other compounds found in marijuana have been studied for their potential effects on glaucoma, a group of painful eye conditions that can lead to blindness. Besides lowering IOP, cannabinoids may also offer neuroprotective effects.
This is according to a group of researchers from the University of New Mexico (UNM) , who recently teamed up with the creators of the Releaf App to investigate the true link between cannabis use and energy levels. Minor Cannabinoids vs. CBD and THC. on a scale of 0-10) improvement in their fatigue symptoms.
In recent years, the landscape of cancer treatment has witnessed a paradigm shift with the emergence of medical cannabis as a potential therapeutic ally. Today we’re here to explore the evolving relationship between medical cannabis and cancer treatment, shedding light on everything potential MMJ patients need to know.
One in 26 people will develop epilepsy in their lifetime. Medical marijuana can alleviate certain side effects and, some research indicates, reduce the number of seizures a patient experiences. Cannabinoids are compounds in cannabis that target cells in the body.
THCjd, also known as Tetrahydrocannabinol jd, is a cannabinoid that has gained attention in recent years. However, research on the specific benefits and effects of THCjd is still in the works. THCjd is a recent cannabinoid discovery as of 2020. However, THCjd is touted as a non-intoxicating cannabinoid.
However, these treatments have not proven to be wholly effective in managing the symptoms of depression. For some individuals, conventional treatments only worsen the symptoms of depression. This has spurred significantly greater interest in alternative remedies, including using cannabis for mental health treatment.
In this blog post, we will explain everything you need to know about the top cannabinoids in cannabis and how they work together with other cannabis compounds to produce an ideal effect on your body. Learning more about other cannabinoids can help you select a cannabis strain that better meets your needs. What Is a Cannabinoid?
In an unprecedented move that embraces the evolving landscape of sports health and wellness, the National Football League (NFL) has recently made a significant investment in cannabidiol (CBD) research, aiming to explore its potential as a pain treatment alternative for players suffering from concussions.
For quite some time, we have known that cannabis can be useful in alleviating the symptoms associated with cancer and its treatments such as chemotherapy. It is commonly used to alleviate the nausea and vomiting associated with such treatment and it can even stimulate the appetite to avoid weight loss. A Summary of the New Study.
When the COVID-19 pandemic began, medical researchers were scrambling to find the best way to treat the viral infection. With that research came various treatment options, some of which were shown to be viable, with others being deemed unsuitable. One such treatment option that researchers have looked into is medical cannabis.
In Miami, Dr. Fernando Fandio-Sende researches innovative approaches to OCD treatment that have emerged, with medical marijuana integrative wellness strategies increasingly recognized as a potential therapeutic avenue worth exploring. For people dealing with OCD, this connection could be really important.
The presence of cannabinoid receptors is well-documented and plays a crucial role in the body’s response to cannabinoids. While these receptors are crucial for regulating pain, immune function, and mood, the possibility of individuals lacking cannabinoid receptors altogether raises intriguing questions.
New cannabis research found that a cannabis-based drug was able to kill pancreatic cancer cells. This powerful combo was even able to destroy all of the cancer cells without damaging any healthy cells, unlike conventional cancer treatments. Cyathus and Cannabinoids: The Cancer-Cell-Killing Duo. What Is Cyathus striatus Fungus?
Researchers have turned to a surprising ally in this fight in recent years: cannabidiol , or CBD. Interestingly, the research demonstrated that even small doses of CBD were sufficient to produce these positive effects. The findings were nothing short of remarkable. This enzyme was inhibited by CBD by 50%.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.
New Breakthrough Treatment for Opiate Addiction with a Unique Combination of Specific Detox Medications, Vivitrol and Reduction of Pressure to the Brain Stem. According to Neurologist & Addiction Medicine Specialist Dr. Russell Surasky, Tips on New and Advanced System of Addiction Treatment Showing Great Success.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Derived from Salvia divinorum, SalA is a unique non-nitrogenous agonist of the kappa-opioid receptor (KOR) with potential use in treatment-resistant depression (TRD), substance use disorder (SUD) and pain. Clinically, there are published reports of the potential benefits of Salvia divinorum in the treatment of TRD. BERLIN, Aug.
The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The psychological symptoms that develop because of the trauma affect mood, cognition, memories (both suppression and the inability to form new memories) and physical health.
According to a 2012 study by University of Bonn scientist Andras Bilkei-Gorzo: “On the cellular level, the cannabinoid system regulates the expression of brain-derived neurotrophic factor and neurogenesis.” When scientists blocked the CB1 cannabinoid receptor, ketamine did not prevent pain.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
The National Football League has taken proactive steps moving forward into the future with a research grant to explore potential therapeutic attributes of CBD, cannabis, and other options to treat pain other than opioids. NFL Research Grant Will Invest in a Bright Future for Athletes and Others. The opioid epidemic is real.
Hence, lupus patients often look for complementary treatments for controlling their symptoms. Fortunately enough, a large body of evidence shows that cannabis may prove to be a good treatment option for lupus. I wanted to see just how good cannabis might be for this condition, and so I decided to go over the available research.
Such extreme levels of heart problems signify a pressing need for research into the root cause(s), not to mention new treatment options. Researchers Examine Composite CVD Risk . The researchers also found a dose-response association between increased frequency of cannabis consumption and an elevated risk of atherosclerotic CVD.
Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. CONVENTIONAL TREATMENT. One of the goals of treating epilepsy is to allow people to continue to live functional and fulfilling life’s epilepsy treatment. CANNABIS AS A POTENTIAL TREATMENT.
These essential oils are called Terpenes, and while research is still evolving, science has proven that these oils can drastically improve a patient’s quality of life. The European Journal of Pharmacology stated that this effect “ may represent a novel route for molecular regulation of endogenous cannabinoid activity.” Dogwalker OG.
Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance.
.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoidresearch, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership. plan to conduct a controlled clinical trial to further understand the effects of CBD in epilepsy treatment.
Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content